Thyroid Gland Disorders Flashcards
most common cause of hypothyroidism world wide
iodine deficiency
most common cause of hypothyroidism in iodine sufficient areas
autoimmune disease and iatrogenic causes
common complaint for hypothyroidism
weight change
first line test performed if thyroid disorder is highly suspected
tsh
most useful physiologic marker of thyroid hormone action
tsh
when is thyroid hormone requested
tsh is abnormal
suspected or known pituitary disease (measure both tsh and ft4)
diagnostic hallmark for autoimmune thyroid disorders
thyroid autoantibodies
can contribute to its development and chronicity
normal values to thyroid ab
Tg-Ab 5-20
TPO-Ab 8-27
TSHR-Ab 0
modality that can confirm presence of a nodule
uts
uses of uts
confirm nodule size benign or suspicious features cervical lymphadenopathy >50% cystic (anechoic, usually benign) posterior location
what is subclinical hypothyroidism
biochemical evidence of hormone deficiency in patients who have few or no apparent clinical features of hypothyroidism
biochem of subclinical hypothyroid
elevated serum tsh and normal ft4
indications for treatment of subclinical hypothyroidism
woman who wishes to concieve or is pregnant
tsh >10 mlU/l
tsh <10 mlU/l with symptoms of hypothyroidism, positive tpo-ab, or evidence of heart disease
treatment for subclinical hypothyroidism
starting treatment: low dose levothyroxine (25-50 ug/d), target normal tsh
not starting treatment: monitor annually
queen anne’s sign
thinning of outer third eyebrows
NOT A SPECIFIC SIGN OF HYPOTHYROIDISM
classification of autoimmune hypothyroidism
hashimoto’s or goitrous thyroiditis: early stage
atrophic thyroiditis: late stage
pathogenesis of autoimmune hypothyroidism
lymphocyte infiltration and fibrosis
risk factors for autoimmune hypothyroidism
hla-dr polymorphisms
female preponderance
environmental factors (5)
clinical manifestations of autoimmune hypothyroidism
initial stages: goiter > hypothyroid
hashimoto’s thyroiditis: irregular, firm consistency, small goiter with mild symptoms
autoimmune thyroiditis: overt symptoms with atrophic thyroid
treatment for hypothyroidism
levothyroxine
no residual thyroid fn: 1.6-1.7 ug/kg or 100-150 ug/d
<60 yo without cvd: 50-100 ug/d
after treatment of graves’: 75-125 ug/day
treatment for hypothyroidism for elderly
20% less levothyroxine
with cad: 12.5-25 ug/d
monitoring of hypothyroidism
check tsh levels, 2 mos after start of treatment
target tsh: lower half of reference range
expected results for hypothy treatment
until 3-6 mos
t/f patients can double the dose after a skipped dose in hypothyroidism
true